Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Fahn

Showing results (131-140 of 170) with videos related to

Pageof 17
Sort By:
Neurobiology of Aging|March 30, 2021
LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson's diseaseYuri L Sosero, Eric Yu, Lynne Krohn, et al.
Drug Safety|May 9, 2003
Benefits and risks of pharmacological treatments for essential tremorKelly E Lyons, Rajesh Pahwa, Cynthia L Comella, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2004
Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutationsLorraine N Clark, Shehla Afridi, Helen Mejia-Santana, et al.
NPJ Parkinson'S Disease|April 26, 2016
<i>SCARB2</i> variants and glucocerebrosidase activity in Parkinson's diseaseRoy N Alcalay, Oren A Levy, Pavlina Wolf, et al.
Brain : a Journal of Neurology|June 29, 2015
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutationsRoy N Alcalay, Oren A Levy, Cheryl C Waters, et al.
Journal of Neurology|September 5, 2021
COVID-19 manifestations in people with Parkinson's disease: a USA cohortYaqian Xu, Matthew Surface, Amanda K Chan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 25, 2014
Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brainJoanna S Fowler, Jean Logan, Nora D Volkow, et al.
Plos One|May 2, 2015
Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body diseaseLorraine N Clark, Robin Chan, Rong Cheng, et al.
European Journal of Medical Genetics|May 30, 2018
Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's diseaseJennifer A Ruskey, Lior Greenbaum, Léanne Roncière, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2013
Designing clinical trials for dystoniaWendy R Galpern, Christopher S Coffey, Alberto Albanese, et al.
Pageof 17

Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
Neurobiology of Aging|March 30, 2021
LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson's diseaseYuri L Sosero, Eric Yu, Lynne Krohn, et al.
Drug Safety|May 9, 2003
Benefits and risks of pharmacological treatments for essential tremorKelly E Lyons, Rajesh Pahwa, Cynthia L Comella, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2004
Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutationsLorraine N Clark, Shehla Afridi, Helen Mejia-Santana, et al.
NPJ Parkinson'S Disease|April 26, 2016
<i>SCARB2</i> variants and glucocerebrosidase activity in Parkinson's diseaseRoy N Alcalay, Oren A Levy, Pavlina Wolf, et al.
Brain : a Journal of Neurology|June 29, 2015
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutationsRoy N Alcalay, Oren A Levy, Cheryl C Waters, et al.
Journal of Neurology|September 5, 2021
COVID-19 manifestations in people with Parkinson's disease: a USA cohortYaqian Xu, Matthew Surface, Amanda K Chan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 25, 2014
Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brainJoanna S Fowler, Jean Logan, Nora D Volkow, et al.
Plos One|May 2, 2015
Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body diseaseLorraine N Clark, Robin Chan, Rong Cheng, et al.
European Journal of Medical Genetics|May 30, 2018
Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's diseaseJennifer A Ruskey, Lior Greenbaum, Léanne Roncière, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2013
Designing clinical trials for dystoniaWendy R Galpern, Christopher S Coffey, Alberto Albanese, et al.
Pageof 17